Literature DB >> 2578167

Comparative effects of various classes of mouse interferons on macrophage activation for tumor cell killing.

J L Pace, S W Russell, P A LeBlanc, D M Murasko.   

Abstract

The effects of mouse interferon-alpha (MuIFN-alpha), -beta (MuIFN-beta), and -gamma (MuIFN-gamma) on macrophage activation for tumor cell killing were determined by using proteose peptone-elicited peritoneal macrophages from C3H/HeN and C3H/HeJ mice under conditions that either included or were free of detectable endotoxin. Alone, under the conditions used, none of the interferons was able to activate macrophages directly for tumor cell killing. However, with a second signal provided to responsive macrophages by contaminating endotoxin, added bacterial lipopolysaccharide (LPS), or heat-killed Listeria monocytogenes (HKLM), all three types of interferon induced cytolytic activity, with MuIFN-gamma approximately 500 to 1000-fold more active than either MuIFN-alpha or -beta. Thus, all three interferons were able to prime macrophages for killing but required a second signal before cytolytic activity could be expressed. When MuIFN-gamma was mixed with either MuIFN-alpha or -beta and placed on macrophages, little or no killing developed. Mixtures of MuIFN-gamma with either MuIFN-alpha or -beta did increase the sensitivity of macrophages to triggering by LPS, however, compared with macrophages treated with MuIFN-gamma alone. The results are collectively important because they i) confirm that significant quantitative differences exist between the various interferons with regard to their capacity to prime macrophages for tumor cell killing; ii) indicate that to be an efficient activator each type of interferon must be combined with a second stimulus, such as LPS or HKLM; iii) show that neither MuIFN-alpha nor -beta can provide an efficient second triggering signal for macrophages that are primed by MuIFN-gamma; and iv) document that mixtures of MuIFN-gamma with either MuIFN-alpha or -beta are most efficient at inducing priming, compared with any one of the interferons used alone.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578167

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Effect of interferon-gamma priming on the activation of murine peritoneal macrophages to tumouricidal state by cisplatin, IL-1, and tumour necrosis factor (TNF): production of IL-1 and TNF.

Authors:  A Sodhi; R K Singh; S M Singh
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

2.  Definition of a lipopolysaccharide-responsive element in the 5'-flanking regions of MuRantes and crg-2.

Authors:  H S Shin; B E Drysdale; M L Shin; P W Noble; S N Fisher; W A Paznekas
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

3.  In vitro characterization of T cells from Mycobacterium w-vaccinated mice.

Authors:  I G Singh; R Mukherjee; G P Talwar; S H Kaufmann
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

4.  Heterogeneous activity of immature and mature cells of the murine monocyte-macrophage lineage derived from different anatomical districts against yeast-phase Candida albicans.

Authors:  T Decker; M L Lohmann-Matthes; M Baccarini
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

5.  Interleukin 2 and interferon-gamma augment anticolon antibody dependent cellular cytotoxicity in ulcerative colitis.

Authors:  T Hibi; M Ohara; M Watanabe; T Kanai; H Takaishi; A Hayashi; Y Hosoda; H Ogata; Y Iwao; S Aiso
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

6.  MDHM, a macrophage-stimulatory product of Mycoplasma fermentans, leads to in vitro interleukin-1 (IL-1), IL-6, tumor necrosis factor, and prostaglandin production and is pyrogenic in rabbits.

Authors:  P F Mühlradt; U Schade
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  Effects of scheduling and ascites-associated macrophages on combined antiproliferative activity of alpha-2b interferon and gamma-interferon in a clonogenic assay.

Authors:  J Higashihara; T Saito; M E Berens; C E Welander
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

8.  IFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread.

Authors:  M Zöller
Journal:  Clin Exp Metastasis       Date:  1988 Sep-Oct       Impact factor: 5.150

9.  Two cis-DNA elements involved in myeloid-cell-specific expression and gamma interferon (IFN-gamma) activation of the human high-affinity Fc gamma receptor gene: a novel IFN regulatory mechanism.

Authors:  C Perez; J Wietzerbin; P D Benech
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

10.  Induction of macrophage antitumor activity by acetylated low density lipoprotein containing lipophilic muramyl tripeptide.

Authors:  J M Shaw; W S Futch; L B Schook
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.